Mary Coleman v. Jason Pharmaceuticals

540 F. App'x 302
CourtCourt of Appeals for the Fifth Circuit
DecidedSeptember 17, 2013
Docket12-11107
StatusUnpublished
Cited by18 cases

This text of 540 F. App'x 302 (Mary Coleman v. Jason Pharmaceuticals) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fifth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Mary Coleman v. Jason Pharmaceuticals, 540 F. App'x 302 (5th Cir. 2013).

Opinion

PER CURIAM: *

Plaintiff-Appellant Mary Kat Coleman (“Coleman”) appeals the district court’s granting of Defendant-Appellee Jason Pharmaceuticals’s (“Pharmaceuticals”) motion for summary judgment on Coleman’s retaliation claim, arguing that she had established a fact issue with respect to whether a causal connection exists between her protected activity and the adverse employment action. Coleman also contends that the district court erred in relying on inadmissible evidence in its decision to grant summary judgment. Finding no reversible error, we AFFIRM for the following reasons.

Causation Element of Retaliation Claim

Coleman contends that she was terminated in retaliation for the complaints she made against other employees. To establish a prima facie case of retaliation under Title VII, a plaintiff “must establish that: (1) he participated in an activity protected by Title VII; (2) his employer took an adverse employment action against him; and (3) a causal connection exists between the protected activity and the adverse em *304 ployment action.” McCoy v. City of Shreveport, 492 F.3d 551, 556-57 (5th Cir.2007). Pursuant to the framework set out in McDonnell Douglas Corp. v. Green, 411 U.S. 792, 802, 93 S.Ct. 1817, 36 L.Ed.2d 668 (1973), “[i]f the employee establishes a prima facie case, the burden shifts to the employer to state a legitimate, non-retaliatory reason for its decision. After the employer states its reason, the burden shifts back to the employee to demonstrate that the employer’s reason is actually a pretext for retaliation.” LeMaire v. Louisiana, 480 F.3d 383, 388-89 (5th Cir.2007) (internal citation omitted).

An employee establishes pretext by showing that the adverse action would not have occurred “but for” the employer’s retaliatory reason for the action. Univ. of Tex. Sw. Med. Ctr. v. Nassar, — U.S. -, 133 S.Ct. 2517, 2533-34, 186 L.Ed.2d 503 (2013). In order to avoid summary judgment, the plaintiff must show “a conflict in substantial evidence” on the question of whether the employer would not have taken the action “but for” the protected activity. Long v. Eastfield College, 88 F.3d 300, 308 (5th Cir.1996) (internal quotation marks omitted).

Coleman worked as a packer at Pharmaceuticals’s Distribution Center. During Coleman’s employment, Faith Underwood was the Human Resources Business Partner. In January of 2011, Underwood conducted an investigation regarding complaints made against three supervisors at Coleman’s work site. Coleman had not made the complaints that instigated this investigation. During this investigation, Underwood received several reports from employees (including Coleman) with respect to the managers’ inappropriate conduct. After completing her investigation, Underwood recommended that the three supervisors be terminated, and they were terminated.

Subsequently, in March of 2011, Coleman met with Underwood and made complaints about her co-workers, alleging that they had acted inappropriately toward her and viewed her as a “whistleblower.” Underwood then interviewed numerous employees about Coleman’s complaints. Instead of providing support for Coleman’s complaints, Underwood concluded that these interviews cast doubt on Coleman’s accusation and also provided negative feedback regarding Coleman’s behavior. Ultimately, Underwood recommended terminating Coleman for two reasons. First, her investigation determined that Coleman made false accusations regarding a coworker’s conduct because she believed he interfered with her working overtime. Second, Underwood concluded that Coleman was a divisive force in the workplace because Coleman had told some of her coworkers not to associate with certain other employees. Coleman was terminated upon Underwood’s recommendation.

The district court assumed, without deciding, that Coleman’s harassment complaints to Underwood in March of 2011 constituted “protected activity.” There is no dispute that Coleman’s termination constituted an adverse action. Apparently assuming that Coleman had established a prima facie case, the district court nonetheless held that Coleman failed to rebut Pharmaceuticals’s legitimate, non-discriminatory reason for terminating Coleman because, other than the temporal proximity of Coleman’s protected activity to her termination, she provided no other evidence of a retaliatory motive. Thus, the issue on appeal is whether the district court erred in finding that Coleman had not shown a conflict in substantial evidence with respect to whether Pharmaceuticals’s allegedly retaliatory motive was the but-for cause of her termination.

*305 Although Coleman admits there is no evidence that Underwood harbored a retaliatory motive, she contends that Underwood’s decision was influenced by her coworkers’s retaliatory motives. When an “ordinary employee” recommends termination of a plaintiff employee for a discriminatory reason, evidence of such animus is not typically attributable to the employer who ultimately terminates the employee. Long, 88 F.3d at 306. But “[i]f the employee can demonstrate that others had influence or leverage over the official decisionmaker, and thus were not ordinary co-workers, it is proper to impute their discriminatory attitudes to the formal deci-sionmaker.” Roberson v. Alltel Info. Servs., 373 F.3d 647, 653 (5th Cir.2004) (citation and internal quotation marks omitted). Thus, to prevail under a cat’s paw theory, a plaintiff must show that a co-worker “exhibited discriminatory animus,” and also that “the same co-worker possessed leverage, or exerted influence, over the titular decisionmaker.” Id. (citations and internal quotation marks omitted).

Coleman summarily asserts that the investigation conducted by Faith Underwood was unduly influenced by her co-workers. Coleman bases this assertion entirely on the fact that, in deciding to recommend Coleman’s termination, Underwood relied on “negative feedback” from her co-workers. Coleman claims that these co-workers “had retaliatory animus toward her” because they viewed her as a “whistleblower” after her complaints. However, Coleman points to nothing in her co-workers’ statements showing animus related to her complaints, and there is no evidence that any of her co-workers actually recommended that she be terminated. Indeed, there is no evidence, outside of her own testimony, that her co-workers even viewed her as a “whistleblower,” as Coleman was not the employee that triggered Underwood’s January 2011 investigation, and she was merely one of “several” employees with whom Underwood met during that investigation. We have noted that an employee cannot establish that an employer’s reason for termination is pretextual simply by “disputing the truth of the underlying facts for that reason.” Haverda v. Hays County,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Meyers v. Walmart
N.D. Texas, 2023
Jones v. McDonough
S.D. Mississippi, 2022
Jones v. Wells Fargo
E.D. Louisiana, 2019
Johnson v. JP Morgan Chase Bank, N.A.
293 F. Supp. 3d 600 (W.D. Louisiana, 2018)
Sabrina Vincent v. College of the Mainland
703 F. App'x 233 (Fifth Circuit, 2017)
Olmeda v. Cameron International Corp.
139 F. Supp. 3d 816 (E.D. Louisiana, 2015)
Rowe v. Jewell
88 F. Supp. 3d 647 (E.D. Louisiana, 2015)
Jones v. Dallas County
47 F. Supp. 3d 469 (N.D. Texas, 2014)
Stoner v. Arkansas Department of Correction
983 F. Supp. 2d 1074 (E.D. Arkansas, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
540 F. App'x 302, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mary-coleman-v-jason-pharmaceuticals-ca5-2013.